Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy

The success of conventional chimeric antigen receptor (CAR) therapy in the treatment of refractory hematologic malignancies has triggered the development of novel exciting experimental CAR technologies. Among them, adaptor CAR platforms have received much attention. They combine the flexibility and...

Descripción completa

Detalles Bibliográficos
Autores principales: Arndt, Claudia, Fasslrinner, Frederick, Loureiro, Liliana R., Koristka, Stefanie, Feldmann, Anja, Bachmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281723/
https://www.ncbi.nlm.nih.gov/pubmed/32455621
http://dx.doi.org/10.3390/cancers12051302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281723/
https://www.ncbi.nlm.nih.gov/pubmed/32455621
http://dx.doi.org/10.3390/cancers12051302

Ejemplares similares